You have 9 free searches left this month | for more free features.

City

Condition

Smoldering Multiple Myeloma (SMM) (2)

Monoclonal Gammopathy of Undetermined Significance (MGUS) (1)

Multiple Myeloma (1)

Overall Status

Not yet recruiting (3)

Sign in for free

Phase

phase 2 (2)

phase 1/phase 2 (1)

Sponsor

Regeneron Pharmaceuticals (3)

Collaborator

Intervention

linvoseltamab (3)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (3)

Study Type

Interventional (3)

linvoseltamab

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Smoldering Multiple Myeloma (SMM) Trial (Linvoseltamab)

Not yet recruiting

Smoldering Multiple Myeloma (SMM)

Linvoseltamab

(no location specified)

Jul 13, 2023

Monoclonal Gammopathy of Undetermined Significance (MGUS), Smoldering Multiple Myeloma (SMM) Trial (Linvoseltamab)

Not yet recruiting

Monoclonal Gammopathy of Undetermined Significance (MGUS)
Smoldering Multiple Myeloma (SMM)

Linvoseltamab

(no location specified)

Nov 17, 2023

Multiple Myeloma Trial (Linvoseltamab)

Not yet recruiting

Multiple Myeloma

Linvoseltamab

(no location specified)

Apr 12, 2023